Lv3
290 积分 2025-08-12 加入
维奈克拉联合化疗治疗初治CBF-AML患者的效果及安全性分析
6小时前
待确认
Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particularly in FLT3-ITD-Negative Patients: ECOG-ACRIN (E-A) E2906 Randomized Study
1个月前
已关闭
Maintenance Decitabine (DAC) Improves Disease-Free (DFS) and Overall Survival (OS) after Intensive Therapy for Acute Myeloid Leukemia (AML) in Older Adults, Particularly in FLT3-ITD-Negative Patients: ECOG-ACRIN (E-A) E2906 Randomized Study
1个月前
已关闭
Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial
2个月前
已完结
甲状腺功能异常患者非甲状腺手术的围手术期管理
2个月前
已完结
Maintenance Therapy in Acute Myeloid Leukemia
3个月前
已完结
Application of CAR-T-cell immunotherapy in patients with refractory/recurrent B-acute lymphoblastic leukemia and its effects on the inflammatory markers of the patients
4个月前
已完结
Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype
5个月前
已完结
Secondary mutational and cytogenetic alterations in core binding factor – Acute myeloid leukemia (CBF-AML): A systematic review and meta-analysis
5个月前
已完结
Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype
5个月前
已完结
皖公网安备34019202002308
